Cite
HARVARD Citation
Sundararajan, V. et al. (2023). Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. Journal of pathology. 259 (2), pp. 194-204. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sundararajan, V. et al. (2023). Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. Journal of pathology. 259 (2), pp. 194-204. [Online].